Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 214
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we predict whether an athlete will sustain an ACL tear?

    Despite consistent investigation, the risk factors responsible for non-contact Anterior Cruciate Ligament (ACL...

    Next Generation Non-Seeing Eye Prosthesis

    This project aims to push the current state of the art in ocular prothestics by integrating a small system of...

    Can we use our immune cells to fight lung disease?

    Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

    Backer Badge Funded